European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

@article{Rockstroh2008EuropeanAC,
  title={European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.},
  author={J{\"u}rgen K. Rockstroh and Sanjay R Bhagani and Yves Benhamou and Raffaele Bruno and Stefan Mauss and Lars Peters and Massimo Puoti and Vicente Soriano and Cristina Tural},
  journal={HIV medicine},
  year={2008},
  volume={9 2},
  pages={82-8}
}
OBJECTIVES With the decline in HIV-associated morbidity and mortality following the introduction of highly active antiretroviral therapy (HAART), liver disease has emerged as a major cause of death in HIV/hepatitis B virus (HBV) and HIV/hepatitis C virus (HCV) coinfected persons. Therefore, screening for underlying viral hepatitis coinfection and the provision of management and treatment recommendations for patients with chronic viral hepatitis are of great importance in preventing, as far as… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
European AIDS Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV - infected adults .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
With the decline in HIV - associated morbidity and mortality following the introduction of highly active antiretroviral therapy ( HAART ) , liver disease has emerged as a major cause of death in HIV / hepatitis B virus ( HBV ) and HIV / hepatitis C virus ( HCV ) coinfected persons .
Therefore , screening for underlying viral hepatitis coinfection and the provision of management and treatment recommendations for patients with chronic viral hepatitis are of great importance in preventing , as far as possible , the development of liver disease .
Therefore , screening for underlying viral hepatitis coinfection and the provision of management and treatment recommendations for patients with chronic viral hepatitis are of great importance in preventing , as far as possible , the development of liver disease .
All Topics